BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24213808)

  • 1. Hypercholesterolemia abrogates the cardioprotection of ischemic postconditioning in isolated rat heart: roles of glycogen synthase kinase-3β and the mitochondrial permeability transition pore.
    Wu N; Zhang X; Guan Y; Shu W; Jia P; Jia D
    Cell Biochem Biophys; 2014 May; 69(1):123-30. PubMed ID: 24213808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking the mitochondrial permeability transition pore with cyclosporine-A can restore cardioprotection of ischemic postconditioning in hypercholesterolemic rat heart.
    Wu N; Li WN; Shu WQ; Lv Y; Jia DL
    Eur Rev Med Pharmacol Sci; 2015; 19(3):446-54. PubMed ID: 25720717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
    Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
    Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.
    Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of ischemia-reperfusion injury by sevoflurane postconditioning involves protein kinase B and glycogen synthase kinase 3 beta activation in isolated rat hearts.
    Fang NX; Yao YT; Shi CX; Li LH
    Mol Biol Rep; 2010 Dec; 37(8):3763-9. PubMed ID: 20217242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.
    Feng J; Lucchinetti E; Ahuja P; Pasch T; Perriard JC; Zaugg M
    Anesthesiology; 2005 Nov; 103(5):987-95. PubMed ID: 16249673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta.
    Park SS; Zhao H; Mueller RA; Xu Z
    J Mol Cell Cardiol; 2006 May; 40(5):708-16. PubMed ID: 16516918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
    Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
    J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
    Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
    J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes abolishes the cardioprotection induced by sevoflurane postconditioning in the rat heart in vivo: roles of glycogen synthase kinase-3β and its upstream pathways.
    Tai W; Shi E; Yan L; Jiang X; Ma H; Ai C
    J Surg Res; 2012 Nov; 178(1):96-104. PubMed ID: 22482760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury.
    Miura T; Nishihara M; Miki T
    J Pharmacol Sci; 2009 Feb; 109(2):162-7. PubMed ID: 19179805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
    Rana A; Sharma S
    Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection of the aged rat heart by GSK-3beta inhibitor is attenuated: age-related changes in mitochondrial permeability transition pore modulation.
    Zhu J; Rebecchi MJ; Glass PS; Brink PR; Liu L
    Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H922-30. PubMed ID: 21217064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.
    Miki T; Miura T; Hotta H; Tanno M; Yano T; Sato T; Terashima Y; Takada A; Ishikawa S; Shimamoto K
    Diabetes; 2009 Dec; 58(12):2863-72. PubMed ID: 19755525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
    Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
    J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart.
    Yadav HN; Singh M; Sharma PL
    Eur J Pharmacol; 2010 Sep; 643(1):78-83. PubMed ID: 20598682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.
    Xi J; Wang H; Mueller RA; Norfleet EA; Xu Z
    Eur J Pharmacol; 2009 Feb; 604(1-3):111-6. PubMed ID: 19135050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats.
    Yang S; Abbott GW; Gao WD; Liu J; Luo C; Hu Z
    J Appl Physiol (1985); 2017 May; 122(5):1095-1105. PubMed ID: 28153944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
    Miura T; Tanno M
    Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.